Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Harvard Business School
QuintilesIMS
Fish and Richardson
UBS
US Army
Johnson and Johnson
Fuji
Healthtrust
Argus Health

Generated: June 18, 2018

DrugPatentWatch Database Preview

TOFRANIL Drug Profile

or, see our see our flat-rate plans

« Back to Dashboard

When do Tofranil patents expire, and when can generic versions of Tofranil launch?

Tofranil is a drug marketed by Novartis and Specgx Llc and is included in three NDAs.

The generic ingredient in TOFRANIL is imipramine pamoate. There are thirty-four drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the imipramine pamoate profile page.
Drug patent expirations by year for TOFRANIL
Pharmacology for TOFRANIL
Synonyms for TOFRANIL
(3-{2-azatricyclo[9.4.0.0;{3,8}]pentadeca-1(11),3(8),4,6,12,14-hexaen-2-yl}propyl)dimethylamine
(3-{2-AZATRICYCLO[9.4.0.0(3),?]PENTADECA-1(11),3(8),4,6,12,14-HEXAEN-2-YL}PROPYL)DIMETHYLAMINE
1-(3-Dimethylaminopropyl)-4,3,6,7-dibenzazepine
1-(3-Dimethylaminopropyl)-4,5-dihydro-2,3,6,7-dibenzazepine
10,11-Dihydro-5-(3-(dimethylamino)propyl)-5H-dibenz[b,f]azepine
10,11-Dihydro-N,N-dimethyl-5H-dibenz[b,f]azepine-5-propanamine
113-52-0 (mono-hydrochloride)
2,2'-(3-Dimethylaminopropylimino)bibenzyl
2,2'-(3-Dimethylaminopropylimino)dibenzyl
3-(10,11-dihydro-5h-dibenz[b,f]azepin-5-yl)propyldimethylamine
3-(10,11-Dihydro-5H-dibenzo[b,f]azepin-5-yl)-N,N-dimethyl-1-propanamine
3-(10,11-Dihydro-5H-dibenzo[b,f]azepin-5-yl)-N,N-dimethyl-1-propanamine #
3-(10,11-dihydro-5H-dibenzo[b,f]azepin-5-yl)-N,N-dimethylpropan-1-amine
3-(10,11-Dihydro-5H-dibenzo[b,f]azepin-5-yl)-N,N-dimethylpropan-1-amine;3-(10,11-Dihydro-5H-dibenzo[b,f]azepin-5-yl)-N,N-dimethylpropan-1-amine
3-(5,6-dihydrobenzo[b][1]benzazepin-11-yl)-N,N-dimethyl-propan-1-amine
3-(5,6-dihydrobenzo[b][1]benzazepin-11-yl)-N,N-dimethylpropan-1-amine
5-(3-(Dimethylamino)propyl)-10,11-dihydro-5H-dibenz(b,f)azepine
5-(3-(Dimethylamino)propyl)-10,f)azepine
5-(3-Dimethylaminopropyl)-10,11-dihydro-5H-dibenzo(b,f)azepine
5-(3-Dimethylaminopropyl)-10,f)azepine
5-[3-(dimethylamino)propyl]-10,11-dihydro-5H-dibenz[b,f]azepine
5,6-Dihydro-N-(3-(dimethylamino)propyl)-11H-dibenz(b,e)azepine
5,6-Dihydro-N-[3-(dimethylamino)propyl]-11H-dibenz[b,e]azepine
5,e)azepine
5,e]azepine
50-49-7
5H-Dibenz(b, 10,11-dihydro-5-(3-(dimethylamino)propyl)-
5H-Dibenz(b, 5-(3-(dimethylamino)propyl)-10,11-dihydro-
5H-Dibenz(b,5-[3-(dimethylamino)propyl]-10,11-dihydro-mixed with ethyl alcohol
5H-Dibenz(b,f)azepine-5-propanamine, 10,11-dihydro-N,N-dimethyl-
5H-Dibenz(b,f)azepine-5-propanamine, 10,11-dihydro-N,N-dimethyl- (9CI)
5H-Dibenz(b,f)azepine-5-propanamine, 10,11-dihydro-N,N-dimethyl-(9CI)
5H-Dibenz(b,f)azepine, 10,11-dihydro-5-(3-(dimethylamino)propyl)-
5H-Dibenz(b,f)azepine, 5-(3-(dimethylamino)propyl)-10,11-dihydro-
5H-Dibenz(b,f)azepine,5-[3-(dimethylamino)propyl]-10,11-dihydro-mixed with ethyl alcohol
5H-Dibenz[b, 10,11-dihydro-N,N-dimethyl-
5H-Dibenz[b, 5-[3-(dimethylamino)propyl]-10,11-dihydro-
5H-Dibenz[b,f]azepine-5-propanamine, 10,11-dihydro-N,N-dimethyl-
5H-Dibenz[b,f]azepine, 5-[3-(dimethylamino)propyl]-10,11-dihydro-
AB00053486
AB00053486_16
AB00053486_17
AB00053486-15
AC1L1GIE
ACM50497
AJ-08423
AK116463
AKOS016010320
AN-41560
Antideprin
Antideprin (TN)
API0006755
AX8134492
BCGWQEUPMDMJNV-UHFFFAOYSA-N
BDBM50010859
Berkomine
BIDD:GT0116
BPBio1_000313
BRD-K38436528-003-05-5
BRN 0256892
BSPBio_000283
BSPBio_002172
C07049
CAS-113-52-0
CAS-50-49-7
CCG-36485
CCRIS 9173
Censtim
Censtin
CHEBI:47499
CHEMBL11
D06ZUK
D08070
DB00458
Declomipramine
Deprimin (TN)
Deprinol (TN)
Depsonil (TN)
Dimipressin
DivK1c_000559
Dpid
DSSTox_CID_23881
DSSTox_GSID_43881
DSSTox_RID_80080
DTXSID1043881
Dyna-zina
Dynaprin
Dynaprin (TN)
EINECS 200-042-1
Eupramin
Eupramin (Salt/Mix)
Eupramin (TN)
FT-0697093
G-22355
G-22355 (Salt/Mix)
GTPL357
HMS2089G08
HSDB 3100
IDI1_000559
Imavate
Imavate (Salt/Mix)
Imidobenzyle
Imipramil (TN)
Imipramin
Imipramina
Imipramina [INN-Spanish]
Imipramina [Italian]
imipramine
Imipramine (INN)
Imipramine [INN:BAN]
Imipraminum
Imipraminum [INN-Latin]
Imiprin
Imizin
Imizin (Salt/Mix)
Imizine
Imizine (Salt/Mix)
Imizinum
Imizinum (Salt/Mix)
Impramine
InChI=1/C19H24N2/c1-20(2)14-7-15-21-18-10-5-3-8-16(18)12-13-17-9-4-6-11-19(17)21/h3-6,8-11H,7,12-15H2,1-2H
Intalpram
Iramil
Irmin
Irmin (TN)
Janimine
Janimine (hydrochloride)
Janimine (TN)
KB-232392
KBio1_000559
KBio2_001395
KBio2_003963
KBio2_006531
KBio3_001392
KBioGR_000391
KBioSS_001395
L000739
Lopac-I-7379
Lopac0_000702
LS-60467
MCULE-9471074673
Melipramin
Melipramin (TN)
Melipramine
MolPort-001-783-692
MRF-0000592
N-(.gamma.-Dimethylaminopropyl)iminodibenzyl
N-(3-Dimethylaminopropyl)-o-iminodibenzyl
N-(gamma-Dimethylaminopropyl)iminodibenzyl
N-(gamma.-Dimethylaminopropyl)iminodibenzyl
NCGC00015563-01
NCGC00015563-02
NCGC00015563-03
NCGC00015563-04
NCGC00015563-05
NCGC00015563-06
NCGC00015563-07
NCGC00015563-08
NCGC00015563-09
NCGC00015563-10
NCGC00015563-11
NCGC00015563-13
NCGC00024253-03
NCGC00024253-04
Nelipramin
NINDS_000559
Norchlorimipramine
Norfranil
NSC 169866
NSC-169866
NSC169866
OGG85SX4E4
Oprea1_200908
PL004956
Pramine
Prazepine
Prestwick0_000072
Prestwick1_000072
Prestwick2_000072
Prestwick3_000072
Promiben
Psychoforin
Psychoforin (Salt/Mix)
PubChem21397
SBI-0050680.P004
SCHEMBL34282
SK-Pramine
SK-Pramine (Salt/Mix)
SPBio_001059
SPBio_002204
Spectrum_000915
Spectrum2_000990
Spectrum3_000466
Spectrum4_000016
Spectrum5_000864
STL416211
Surplix
Surplix (Salt/Mix)
Surplix (TN)
Timolet
Tofranil (free base)
Tofranil (hydrochloride)
Tofranil (Salt/Mix)
Tofranil (TN)
Tofranil base
Tofranil-PM
Tofranil, base
Tofranil(TN)
Tofraniln A
Tox21_110174
Tox21_110174_1
UNII-OGG85SX4E4
W-109253
W0042
WLN: T C676 BN&T&J B3N1&1
ZINC20245

US Patents and Regulatory Information for TOFRANIL

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Novartis TOFRANIL imipramine hydrochloride INJECTABLE;INJECTION 011838-002 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Specgx Llc TOFRANIL-PM imipramine pamoate CAPSULE;ORAL 017090-004 Approved Prior to Jan 1, 1982 DISCN Yes No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Specgx Llc TOFRANIL imipramine hydrochloride TABLET;ORAL 087846-001 May 22, 1984 AB RX No Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Specgx Llc TOFRANIL-PM imipramine pamoate CAPSULE;ORAL 017090-001 Approved Prior to Jan 1, 1982 DISCN Yes No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Accenture
Fish and Richardson
Fuji
Merck
Dow
Express Scripts
Teva
UBS
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.